Australia’s Therapeutic Goods Administration (TGA) is holding consultations on information sharing under clinical trial schemes and its proposed comments on an international guideline for good clinical practice (GCP).
The European Medicines Agency (EMA) and its African counterpart have published a joint position paper to support the timely start of Ebola vaccine clinical trials.
The Pharmaceuticals and Medical Devices Agency (PMDA) has published advice on ensuring the safety of healthy adult participants in Japanese bioequivalence studies.